Successful non‐neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB)

Cancer

Volumn 57, Issue 1, 1986, Pages 6-11

  Cohen, Ian J ^a,b   Vogel, Ruth ^a,b   Matz, Shoshana ^a,b   Weitz, Raphael ^a,b   Mor, Celia ^a,b   Stern, Sidi ^a,b   Zaizov, Rina ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; DEXAMETHASONE; METHOTREXATE; VINCRISTINE; VINCRISTINE SULFATE;

BASAL GANGLION; BLOOD AND HEMOPOIETIC SYSTEM; BOY; BRAIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD CANCER; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NERVOUS SYSTEM; NEUROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; THERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHILD, PRESCHOOL; DEXAMETHASONE; HUMANS; KINETICS; LYMPHOMA; MALE; METHOTREXATE; VINCRISTINE;

EID: 0022630705     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19860101)57:1<6::AID-CNCR2820570104>3.0.CO;2-B     Document Type: Article

References (34)

1. An immunohistological study of immunoglobulin content of primary central nervous system lymphomas
2. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: An assessment of risk factors
3. Immunoperoxidase techniques
4. The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique
5. Competitive protein binding assay for methotrexate
6. Neoplasms of the reticuloendothelial system of the brain
7. Reticulum cell sarcoma of the brain
8. Primary lymphoma of the central nervous system
9. Radiation therapy for intracranial lymphoma
10. Reticuloendothelial (perivascular) sarcoma of the brain
11. Lymphoma after organ transplantation: Radiologic manifestations in the central nervous system, thorax and abdomen
12. The Wiskott Adrich syndrome in the United States and Canada 1892–1979
13. Spontaneous regression of intracerebral lymphoma
14. Successful treatment with methotrexate of a multicentric lymphoma of the central nervous system
15. Treatment of leukemia with large doses of methotrexate and folic acid: Clinical‐biochemical correlates
16. Successful treatment of recurrent primary central nervous system lymphoma with high dose methotrexate
17. Treatment of central nervous system tumors with methotrexate
18. Radiation induced intracranial meningiomas
19. Are cognitive and educational development affected by age at which prophylactic therapy is given in acute lymphoblastic leukemia?
20. The effect of photon irradiation on blood brain barrier permeability to methotrexate in mice
21. Effects of chemotherapy on the central nervous system: A study of parenteral methotrexate in long term survivors of leukemia and lymphoma in childhood
22. Lack of dihydrofolate reductase activity in brain tissues of mammalian species: possible implications
23. Difolate reductase in present in brain
24. Transport characteristics of folates in cerebrospinal fluid: A study utilizing doubly labelled 5‐methyltetrahydrofolate and 5‐formyl tetrahydrofolate
25. Methotrexate distribution in cerebrospinal fluid after intravenous ventricular and lumbar injection
26. Serum and cerebrospinal fluid distribution of 5‐methyltetrahydrofolate after intravenous calcium leucovorin and intra‐ommaya administration in patients with meningeal carcinomatosis
27. Rescue techniques in cancer chemotherapy: Use of leucovorin and other rescue techniques after methotrexate treatment
28. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high‐dose methotrexate
29. Leucoencephalopathy following high‐dose methotrexate chemotherapy with leucovorin rescue
30. Methotrexate and central nervous system toxicity
31. Chronic methotrexate toxicity to the central nervous system